Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series

Tomoya Yokota, Hiroki Yukino, Mihoko Doi, Hisatsugu Ohori

Open source

DOI
10.1002/hed.27346
Published
2023-03-16
Container
Head &amp; Neck
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hed.27346,
  title = {Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series},
  author = {Tomoya Yokota and Hiroki Yukino and Mihoko Doi and Hisatsugu Ohori},
  year = {2023},
  journal = {Head \&amp; Neck},
  doi = {10.1002/hed.27346},
  url = {https://doi.org/10.1002/hed.27346}
}

RIS

TY  - JOUR
TI  - Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series
AU  - Tomoya Yokota
AU  - Hiroki Yukino
AU  - Mihoko Doi
AU  - Hisatsugu Ohori
PY  - 2023
JO  - Head &amp; Neck
DO  - 10.1002/hed.27346
UR  - https://doi.org/10.1002/hed.27346
ER  - 

APA

Yokota, T., Yukino, H., Doi, M., & Ohori, H. (2023). Real‐world experience of tropomyosin receptor kinase inhibition with entrectinib in <scp><i>ETV6‐NTRK3</i></scp> positive metastatic salivary secretory carcinoma: A case series. Head &amp; Neck. https://doi.org/10.1002/hed.27346

Source records